Arecoline as a Novel Scaffold Targeting the ATAD2 Bromodomain for Cell Cycle Modulation.

Saved in:
Bibliographic Details
Title: Arecoline as a Novel Scaffold Targeting the ATAD2 Bromodomain for Cell Cycle Modulation.
Authors: Lin TS; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.; Guangdong Provincial Key Laboratory of Digital Biology and Drug Development, The Chinese University of Hong Kong, Shenzhen 518172, China., Wan J; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.; Guangdong Provincial Key Laboratory of Digital Biology and Drug Development, The Chinese University of Hong Kong, Shenzhen 518172, China., He J; Department of General Practice, Shenzhen Luohu People's Hospital, Shenzhen 518000, China.; Luohu Clinical College, Shantou University Medical College, Shenzhen 518000, China., Cui S; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.; Guangdong Provincial Key Laboratory of Digital Biology and Drug Development, The Chinese University of Hong Kong, Shenzhen 518172, China., Huang Y; Department of General Practice, Shenzhen Luohu People's Hospital, Shenzhen 518000, China.; Luohu Clinical College, Shantou University Medical College, Shenzhen 518000, China., Zhang B; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China., Huang HY; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.; Guangdong Provincial Key Laboratory of Digital Biology and Drug Development, The Chinese University of Hong Kong, Shenzhen 518172, China., Zhu K; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China., Chen J; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China., Zhang T; Better Way Group-Chinese University of Hong Kong (Shenzhen) Warshel Joint Laboratory for Skin Health and Active Molecule Innovation, Shenzhen 518172, China., Li S; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.; Guangdong Provincial Key Laboratory of Digital Biology and Drug Development, The Chinese University of Hong Kong, Shenzhen 518172, China., Hu L; Department of Electrical & Computer Engineering, University of Illinois at Chicago, Chicago, IL 60607, USA., Wang Y; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.; Guangdong Provincial Key Laboratory of Digital Biology and Drug Development, The Chinese University of Hong Kong, Shenzhen 518172, China., Huang HD; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.; Guangdong Provincial Key Laboratory of Digital Biology and Drug Development, The Chinese University of Hong Kong, Shenzhen 518172, China.; Better Way Group-Chinese University of Hong Kong (Shenzhen) Warshel Joint Laboratory for Skin Health and Active Molecule Innovation, Shenzhen 518172, China.; Department of Endocrinology, Key Laboratory of Endocrinology of National Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China., Tang P; Department of General Practice, Shenzhen Luohu People's Hospital, Shenzhen 518000, China.; Luohu Clinical College, Shantou University Medical College, Shenzhen 518000, China., Lin YC; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.; Guangdong Provincial Key Laboratory of Digital Biology and Drug Development, The Chinese University of Hong Kong, Shenzhen 518172, China.; Better Way Group-Chinese University of Hong Kong (Shenzhen) Warshel Joint Laboratory for Skin Health and Active Molecule Innovation, Shenzhen 518172, China.
Source: Pharmaceutics [Pharmaceutics] 2026 Mar 03; Vol. 18 (3). Date of Electronic Publication: 2026 Mar 03.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41900810
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Arecoline as a Novel Scaffold Targeting the ATAD2 Bromodomain for Cell Cycle Modulation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lin+TS%22">Lin TS</searchLink>; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.; Guangdong Provincial Key Laboratory of Digital Biology and Drug Development, The Chinese University of Hong Kong, Shenzhen 518172, China.<br /><searchLink fieldCode="AU" term="%22Wan+J%22">Wan J</searchLink>; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.; Guangdong Provincial Key Laboratory of Digital Biology and Drug Development, The Chinese University of Hong Kong, Shenzhen 518172, China.<br /><searchLink fieldCode="AU" term="%22He+J%22">He J</searchLink>; Department of General Practice, Shenzhen Luohu People's Hospital, Shenzhen 518000, China.; Luohu Clinical College, Shantou University Medical College, Shenzhen 518000, China.<br /><searchLink fieldCode="AU" term="%22Cui+S%22">Cui S</searchLink>; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.; Guangdong Provincial Key Laboratory of Digital Biology and Drug Development, The Chinese University of Hong Kong, Shenzhen 518172, China.<br /><searchLink fieldCode="AU" term="%22Huang+Y%22">Huang Y</searchLink>; Department of General Practice, Shenzhen Luohu People's Hospital, Shenzhen 518000, China.; Luohu Clinical College, Shantou University Medical College, Shenzhen 518000, China.<br /><searchLink fieldCode="AU" term="%22Zhang+B%22">Zhang B</searchLink>; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.<br /><searchLink fieldCode="AU" term="%22Huang+HY%22">Huang HY</searchLink>; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.; Guangdong Provincial Key Laboratory of Digital Biology and Drug Development, The Chinese University of Hong Kong, Shenzhen 518172, China.<br /><searchLink fieldCode="AU" term="%22Zhu+K%22">Zhu K</searchLink>; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.<br /><searchLink fieldCode="AU" term="%22Chen+J%22">Chen J</searchLink>; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.<br /><searchLink fieldCode="AU" term="%22Zhang+T%22">Zhang T</searchLink>; Better Way Group-Chinese University of Hong Kong (Shenzhen) Warshel Joint Laboratory for Skin Health and Active Molecule Innovation, Shenzhen 518172, China.<br /><searchLink fieldCode="AU" term="%22Li+S%22">Li S</searchLink>; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.; Guangdong Provincial Key Laboratory of Digital Biology and Drug Development, The Chinese University of Hong Kong, Shenzhen 518172, China.<br /><searchLink fieldCode="AU" term="%22Hu+L%22">Hu L</searchLink>; Department of Electrical & Computer Engineering, University of Illinois at Chicago, Chicago, IL 60607, USA.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.; Guangdong Provincial Key Laboratory of Digital Biology and Drug Development, The Chinese University of Hong Kong, Shenzhen 518172, China.<br /><searchLink fieldCode="AU" term="%22Huang+HD%22">Huang HD</searchLink>; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.; Guangdong Provincial Key Laboratory of Digital Biology and Drug Development, The Chinese University of Hong Kong, Shenzhen 518172, China.; Better Way Group-Chinese University of Hong Kong (Shenzhen) Warshel Joint Laboratory for Skin Health and Active Molecule Innovation, Shenzhen 518172, China.; Department of Endocrinology, Key Laboratory of Endocrinology of National Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.<br /><searchLink fieldCode="AU" term="%22Tang+P%22">Tang P</searchLink>; Department of General Practice, Shenzhen Luohu People's Hospital, Shenzhen 518000, China.; Luohu Clinical College, Shantou University Medical College, Shenzhen 518000, China.<br /><searchLink fieldCode="AU" term="%22Lin+YC%22">Lin YC</searchLink>; Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.; Guangdong Provincial Key Laboratory of Digital Biology and Drug Development, The Chinese University of Hong Kong, Shenzhen 518172, China.; Better Way Group-Chinese University of Hong Kong (Shenzhen) Warshel Joint Laboratory for Skin Health and Active Molecule Innovation, Shenzhen 518172, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101534003%22">Pharmaceutics</searchLink> [Pharmaceutics] 2026 Mar 03; Vol. 18 (3). <i>Date of Electronic Publication: </i>2026 Mar 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101534003 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1999-4923 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219994923%22">19994923 </searchLink><i>NLM ISO Abbreviation: </i>Pharmaceutics <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41900810
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/pharmaceutics18030324
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Arecoline as a Novel Scaffold Targeting the ATAD2 Bromodomain for Cell Cycle Modulation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lin TS
      – PersonEntity:
          Name:
            NameFull: Wan J
      – PersonEntity:
          Name:
            NameFull: He J
      – PersonEntity:
          Name:
            NameFull: Cui S
      – PersonEntity:
          Name:
            NameFull: Huang Y
      – PersonEntity:
          Name:
            NameFull: Zhang B
      – PersonEntity:
          Name:
            NameFull: Huang HY
      – PersonEntity:
          Name:
            NameFull: Zhu K
      – PersonEntity:
          Name:
            NameFull: Chen J
      – PersonEntity:
          Name:
            NameFull: Zhang T
      – PersonEntity:
          Name:
            NameFull: Li S
      – PersonEntity:
          Name:
            NameFull: Hu L
      – PersonEntity:
          Name:
            NameFull: Wang Y
      – PersonEntity:
          Name:
            NameFull: Huang HD
      – PersonEntity:
          Name:
            NameFull: Tang P
      – PersonEntity:
          Name:
            NameFull: Lin YC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 03
              Text: 2026 Mar 03
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1999-4923
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Pharmaceutics
              Type: main
ResultId 1